{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:07:11Z","timestamp":1753877231439,"version":"3.41.2"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100005918","name":"Christian Medical College, Vellore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005918","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Invasive Aspergillosis (IA) is a potentially lethal infection in high-risk haemato-oncology patients. Since traditional diagnostic methods have many inherent challenges, Polymerase Chain Reaction (PCR) has been used to diagnose IA. This prospective study evaluated a commercial AsperGenius multiplex real-time PCR for its clinical utility in diagnosing IA compared with galactomannan (GM) testing serum samples from haemato-oncology patients with clinically suspected IA. A total of 107 patients were recruited between April 2022 and March 2023. Serum samples (n\u00a0=\u00a0113) collected from those patients for the routine diagnosis by GM Enzyme Linked Immuno-Sorbent Assay (ELISA) were subjected to PCR. The patients were categorised into probable, possible, and no IA based on revised (2020) and previous (2008) European Organization for Research and Treatment of Cancer and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC-MSG) criteria. The performance characteristics of PCR and GM were calculated against the EORTC criteria by combining probable and possible cases as diseased groups. Among the 107 recruited patients, 93 were categorised into probable\/possible IA (diseased group) and 14 into no IA group. The PCR was positive in 53 samples from 49 patients. The sensitivity and specificity of single positive PCR and GM were 51.61% [95% confidence interval, 41\u201362], 92.86% (66.1\u201399.8) and 26.88% (18.2\u201337.1), 92.86% (66.1\u201399.8), respectively. The combination-based strategy (GM and\/or PCR positive) exhibited a moderate sensitivity of 62.37% (51\u201372.2) and a specificity of 85.71% (57.2\u201398.2). To conclude, the combined strategy of serum GM and\/or PCR positivity, along with radiological findings that fulfilled the EORTC\/MSG criteria, has improved the diagnosis of probable IA among high-risk haematological patients with clinically suspected IA.<\/jats:p>","DOI":"10.1093\/mmy\/myae100","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T04:03:32Z","timestamp":1728705812000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis of invasive aspergillosis in haemato-oncology patients in a routine diagnostic setting"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9295-1118","authenticated-orcid":false,"given":"Dhanalakshmi","family":"Solaimalai","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology, Christian Medical College , Vellore 632002 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemol","family":"Varghese","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Christian Medical College , Vellore 632002 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujith","family":"Karumathil","sequence":"additional","affiliation":[{"name":"Department of Haematology, Christian Medical College , Vellore 632002 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uday","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Department of Haematology, Christian Medical College , Vellore 632002 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biju","family":"George","sequence":"additional","affiliation":[{"name":"Department of Haematology, Christian Medical College , Vellore 632002 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy Sarojini","family":"Michael","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Christian Medical College , Vellore 632002 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"issue":"6","key":"2024102415543359100_bib1","first-page":"341","article-title":"Pulmonary aspergillosis: Early diagnosis improves survival","volume":"62","author":"von\u00a0Eiff","year":"1995","journal-title":"Respir Int Rev Thorac Dis"},{"issue":"4","key":"2024102415543359100_bib2","doi-asserted-by":"crossref","first-page":"e01913","DOI":"10.1128\/JCM.01913-18","article-title":"Diagnosing invasive pulmonary aspergillosis in hematology patients: A retrospective multicenter evaluation of a novel lateral flow device","volume":"57","author":"Mercier","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"5","key":"2024102415543359100_bib3","doi-asserted-by":"crossref","first-page":"e37067","DOI":"10.1097\/MD.0000000000037067","article-title":"Diagnostic performance of serum galactomannan and \u03b2-d-glucan for invasive aspergillosis in suspected patients: A meta-analysis","volume":"103","author":"Huang","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"2024102415543359100_bib4","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De\u00a0Pauw","year":"2008","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"Supplement_2","key":"2024102415543359100_bib5","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1093\/cid\/ciaa1865","article-title":"Aspergillus polymerase chain reaction\u2014An update on technical recommendations, clinical applications, and justification for inclusion in the second revision of the EORTC\/MSGERC definitions of invasive fungal disease","volume":"72","author":"White","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2024102415543359100_bib6","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"suppl_1","key":"2024102415543359100_bib7","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1093\/mmy\/myx091","article-title":"Diagnosis of aspergillosis by PCR: Clinical considerations and technical tips","volume":"56","author":"Barnes","year":"2018","journal-title":"Med Mycol"},{"issue":"4","key":"2024102415543359100_bib8","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/cncr.10349","article-title":"Polymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients","volume":"94","author":"Raad","year":"2002","journal-title":"Cancer"},{"issue":"1","key":"2024102415543359100_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1365-2141.2000.01795.x","article-title":"Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction","volume":"108","author":"Williamson","year":"2000","journal-title":"Br J Haematol"},{"issue":"10","key":"2024102415543359100_bib10","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/jof9100967","article-title":"An overview of systematic reviews of Polymerase Chain Reaction (PCR) for the diagnosis of invasive aspergillosis in immunocompromised people: A report of the Fungal PCR Initiative (FPCRI)\u2014An ISHAM working group","volume":"9","author":"Cruciani","year":"2023","journal-title":"J Fungi"},{"issue":"6","key":"2024102415543359100_bib11","doi-asserted-by":"crossref","first-page":"562.e1","DOI":"10.1016\/j.cmi.2016.01.027","article-title":"Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and nonneutropenic patients","volume":"22","author":"Imbert","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"2024102415543359100_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1473-3099(09)70019-2","article-title":"Use of PCR for diagnosis of invasive aspergillosis: Systematic review and meta-analysis","volume":"9","author":"Mengoli","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"2024102415543359100_bib13","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/JCM.01365-14","article-title":"PCR in diagnosis of invasive aspergillosis: A meta-analysis of diagnostic performance","volume":"52","author":"Arvanitis","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"9","key":"2024102415543359100_bib14","first-page":"CD009551","article-title":"Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people","volume":"9","author":"Cruciani","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"Pt 4","key":"2024102415543359100_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1099\/jmm.0.017418-0","article-title":"Dynamics of extracellular release of Aspergillus fumigatus DNA and galactomannan during growth in blood and serum","volume":"59","author":"Morton","year":"2010","journal-title":"J Med Microbiol"},{"issue":"5","key":"2024102415543359100_bib16","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1128\/JCM.44.5.1711-1718.2006","article-title":"In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-\u03b2-d-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis","volume":"44","author":"Mennink-Kersten","year":"2006","journal-title":"J Clin Microbiol."},{"issue":"8","key":"2024102415543359100_bib17","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/cid\/civ555","article-title":"Galactomannan and polymerase chain reaction-based screening for invasive aspergillosis among high-risk hematology patients: A diagnostic meta-analysis","volume":"61","author":"Arvanitis","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2024102415543359100_bib18","first-page":"268","article-title":"Performance of the AsperGenius R \u00a9 PCR Assay for Detecting Azole Resistant Aspergillus fumigatus in BAL Fluids from Allogeneic HSCT Recipients: A Prospective Cohort Study from Essen, West Germany","volume":"58","author":"Pelzer","year":"2020","journal-title":"Med Mycol."},{"issue":"2","key":"2024102415543359100_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/picr.PICR_41_18","article-title":"Understanding the properties of diagnostic tests\u2013\u2013Part 2: Likelihood ratios","volume":"9","author":"Ranganathan","year":"2018","journal-title":"Perspect Clin Res"},{"issue":"1","key":"2024102415543359100_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/cid\/ciad141","article-title":"Clinical impact of polymerase chain reaction-based Aspergillus and azole resistance detection in invasive aspergillosis: A prospective multicenter study","volume":"77","author":"Huygens","year":"2023","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"7","key":"2024102415543359100_bib21","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/bmt.2010.219","article-title":"Silent and prolonged Aspergillus DNAemia in oncohematological patients receiving antifungal prophylaxis: A new phenomenon with clinical implications","volume":"46","author":"Meije","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2024102415543359100_bib22","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.cmi.2022.02.026","article-title":"The impact of the updated EORTC\/MSG criteria on the classification of hematological patients with suspected invasive pulmonary aspergillosis","volume":"28","author":"Lamberink","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2024102415543359100_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12288-019-01173-y","article-title":"A prospective observational multi-institutional study on invasive fungal infections following chemotherapy for acute myeloid leukemia (MISFIC study): A real world scenario from India","volume":"36","author":"George","year":"2020","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"2","key":"2024102415543359100_bib24","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.ijid.2012.09.004","article-title":"Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005\u20132009","volume":"17","author":"Racil","year":"2013","journal-title":"Int J Infect Dis"},{"issue":"3","key":"2024102415543359100_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/ciu833","article-title":"Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: A randomized controlled trial","volume":"60","author":"Aguado","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2024102415543359100_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/jof5030055","article-title":"Invasive aspergillosis by Aspergillus flavus: Epidemiology, diagnosis, antifungal resistance, and management","volume":"5","author":"Rudramurthy","year":"2019","journal-title":"J Fungi"},{"key":"2024102415543359100_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcrc.2019.02.005","article-title":"Epidemiology and clinical outcomes of invasive mould infections in Indian intensive care units (FISF study)","volume":"51","author":"Chakrabarti","year":"2019","journal-title":"J Crit Care"},{"issue":"11","key":"2024102415543359100_bib28","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1128\/JCM.05316-11","article-title":"Evaluation of Aspergillus PCR protocols for testing serum specimens","volume":"49","author":"White","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"9","key":"2024102415543359100_bib29","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JCM.00905-15","article-title":"Clinical performance of Aspergillus PCR for testing serum and plasma: A study by the European Aspergillus PCR initiative","volume":"53","author":"White","year":"2015","journal-title":"J Clin Microbiol"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myae100\/59726063\/myae100.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/62\/10\/myae100\/60033862\/myae100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/62\/10\/myae100\/60033862\/myae100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T15:54:45Z","timestamp":1729785285000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myae100\/7819144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,4]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myae100","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"type":"print","value":"1369-3786"},{"type":"electronic","value":"1460-2709"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,10]]},"article-number":"myae100"}}